Merck Temodar Recall Issued After Cracked Caps Found On Cancer Drug Bottles

Merck is recalling about 276,000 bottles of Temodar and generic temozolomide, after it was determined that some bottles of the cancer drug may have cracked caps, which could allow children access. 

The Temodar and Temozolomide (generic) bottle recall was announced by Merck and the U.S. Consumer Product Safety Commission (CPSC) on August 18. The recall came after Merck realized that hundreds of the bottles had cracked child-resistant bottle caps that could allow children access to the potent drugs inside, resulting in poisoning.

Merck and the CPSC are asking all customers, including patients, pharmacists and health care professionals, to inspect all bottles of Temodar and generic temozolomide capsules for potential cracks. If the cap is cracked the bottles should be removed from any potential access by children immediately. No incidents of child poisoning have been reported.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

“Merck believes that approximately 1,100 bottles out of an estimated 276,000 distributed bottles of TEMODAR and Temozolomide capsules (generic) could potentially have cracked caps,” Merck said in a press release. “Those bottles could be at wholesalers, pharmacies, healthcare providers or with patients.”

The side effects of Temodar, a powerful cancer-fighting drug, can include:

  • Seizures
  • A potentially fatal allergic skin reaction known as Stevens-Johnson Syndrome (SJS)
  • Increased risk of infection
  • Dry cough
  • Pain while urinating
  • Nausea
  • Jaundice
  • Hair loss
  • Insomnia

The recall affects about 276,000 five and 14-count bottles of Temodar and Temozolomide (generic) capsules, distributed in brown class bottles with white plastic child-resistant caps. The affected drugs were sold as a prescription medication at clinics and pharmacies from July 2013 to August 2015.

Both were manufactured by Merck, but the generic temozolomide capsules were distributed by Sandoz.

The CPSC recommends that consumers with cracked bottle caps contact Merck for a replacement cap and store the drugs high, out of sight and out of reach of young children. Consumers with questions can contact the Merck Information Center by calling (800) 943-8069.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL
Plaintiffs Oppose Phased Discovery Over Suboxone Tooth Decay Risks in MDL (Posted yesterday)

Plaintiffs say a federal judge should not waste time on a phased discovery plan requiring them to first prove Suboxone strips can cause tooth decay, saying the science is obvious and such a plan could delay resolution of hundreds of product liability lawsuits.